83027-0038 NDC - VIRILITY LIQUESCENCE (AVENA SATIVA, DAMIANA, BERBERIS VULGARIS, EPIMEDIUM GRANDIFLORUM, GLYCERINUM, SABAL SERRULATA, IODIUM, LECITHIN, FERRUM MURIATICUM, NATRUM MURIATICUM, AGNUS CASTUS, BUFO RANA, CINCHONA OFFICINALIS, HUMAN GROWTH HORMONE (HGH), ORCHITINUM (BOVINE), PHOSPHORICUM ACIDUM, PHOSPHORUS, SELENIUM METALLICUM, ZINCUM VALERIANICUM, OOPHORINUM (SUIS), SEPIA)

Drug Information

Product NDC: 83027-0038

Proprietary Name: Virility Liquescence

Non Proprietary Name: Avena Sativa, Damiana, Berberis Vulgaris, Epimedium Grandiflorum, Glycerinum, Sabal Serrulata, Iodium, Lecithin, Ferrum Muriaticum, Natrum Muriaticum, Agnus Castus, Bufo Rana, Cinchona Officinalis, Human Growth Hormone (HGH), Orchitinum (Bovine), Phosphoricum Acidum, Phosphorus, Selenium Metallicum, Zincum Valerianicum, Oophorinum (Suis), Sepia

Active Ingredient(s):
  • 2 [hp_X]/mL AVENA SATIVA FLOWERING TOP;
  • 3 [hp_X]/mL BERBERIS VULGARIS ROOT BARK;
  • 12 [hp_X]/mL BOS TAURUS TESTICLE;
  • 12 [hp_X]/mL BUFO BUFO CUTANEOUS GLAND;
  • 8 [hp_X]/mL CHASTE TREE FRUIT;
  • 12 [hp_X]/mL CINCHONA OFFICINALIS BARK;
  • 4 [hp_X]/mL EGG PHOSPHOLIPIDS;
  • 3 [hp_X]/mL EPIMEDIUM GRANDIFLORUM TOP;
  • 4 [hp_X]/mL FERRIC CHLORIDE HEXAHYDRATE;
  • 3 [hp_X]/mL GLYCERIN;
  • 4 [hp_X]/mL IODINE;
  • 12 [hp_X]/mL PHOSPHORIC ACID;
  • 12 [hp_X]/mL PHOSPHORUS;
  • 3 [hp_X]/mL SAW PALMETTO;
  • 12 [hp_X]/mL SELENIUM;
  • 30 [hp_X]/mL SEPIA OFFICINALIS JUICE;
  • 4 [hp_X]/mL SODIUM CHLORIDE;
  • 12 [hp_X]/mL SOMATROPIN;
  • 16 [hp_X]/mL SUS SCROFA OVARY;
  • 2 [hp_X]/mL TURNERA DIFFUSA LEAFY TWIG;
  • 12 [hp_X]/mL ZINC VALERATE DIHYDRATE


Administration Route(s): ORAL

Dosage Form(s): LIQUID

Pharmacy Class(es):
  • Allergens [CS];
  • Cell-mediated Immunity [PE];
  • Glycerol [CS];
  • Human Growth Hormone [CS];
  • Increased Histamine Release [PE];
  • Increased IgG Production [PE];
  • Iron [CS];
  • Non-Standardized Chemical Allergen [EPC];
  • Parenteral Iron Replacement [EPC];
  • Phosphate Binder [EPC];
  • Phosphate Chelating Activity [MoA];
  • Recombinant Human Growth Hormone [EPC]

Labeler Information

Labeler Name: Nutritional Specialties, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:3/29/2023

Package Information

No. Package Code Package Description Billing Unit
183027-0038-1120 mL in 1 BOTTLE, GLASS (83027-0038-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC83027-0038The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEVirility LiquescenceThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEAvena Sativa, Damiana, Berberis Vulgaris, Epimedium Grandiflorum, Glycerinum, Sabal Serrulata, Iodium, Lecithin, Ferrum Muriaticum, Natrum Muriaticum, Agnus Castus, Bufo Rana, Cinchona Officinalis, Human Growth Hormone (HGH), Orchitinum (Bovine), Phosphoricum Acidum, Phosphorus, Selenium Metallicum, Zincum Valerianicum, Oophorinum (Suis), SepiaThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE3/29/2023This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMENutritional Specialties, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEAVENA SATIVA FLOWERING TOP; BERBERIS VULGARIS ROOT BARK; BOS TAURUS TESTICLE; BUFO BUFO CUTANEOUS GLAND; CHASTE TREE FRUIT; CINCHONA OFFICINALIS BARK; EGG PHOSPHOLIPIDS; EPIMEDIUM GRANDIFLORUM TOP; FERRIC CHLORIDE HEXAHYDRATE; GLYCERIN; IODINE; PHOSPHORIC ACID; PHOSPHORUS; SAW PALMETTO; SELENIUM; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE; SOMATROPIN; SUS SCROFA OVARY; TURNERA DIFFUSA LEAFY TWIG; ZINC VALERATE DIHYDRATEAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH2; 3; 12; 12; 8; 12; 4; 3; 4; 3; 4; 12; 12; 3; 12; 30; 4; 12; 16; 2; 12 
ACTIVE INGRED UNIT[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL 
PHARM CLASSESAllergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Human Growth Hormone [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Iron [CS], Non-Standardized Chemical Allergen [EPC], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Recombinant Human Growth Hormone [EPC] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 4/3/2023